GlassScriptPhysician profile
Kimberly Brunson
NPI 1477785798
$4,323.29
in general payments reported to CMS, 2019-2025
22 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $406 · 2022: $383 · 2023: $2,951 · 2024: $195 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,338 · Food and Beverage: $1,097 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,337.67 |
| Food and Beverage | $1,097.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midmark Corporation | $2,491.01 | 2023 | |
| Amgen INC. | $545.95 | 2021-2025 | Repatha, Otezla, Evenity |
| Novo Nordisk INC | $326.81 | 2021-2024 | Wegovy |
| Axsome Therapeutics, INC. | $153.74 | 2025 | Auvelity |
| Lilly USA, LLC | $151.85 | 2024-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $126.59 | 2022 | |
| Astellas Pharma US INC | $99.99 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $85.39 | 2021-2025 | Farxiga, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $71.05 | 2022-2023 | |
| Glaxosmithkline, LLC. | $48.92 | 2021 | |
| Insulet Corporation | $38.14 | 2023 | Omnipod |
| Abbott Laboratories | $35.84 | 2023-2024 | Freestyle Libre 3 |
| Supernus Pharmaceuticals, INC. | $22.20 | 2021 | |
| Itamar Medical INC | $20.70 | 2023-2024 | Watchpatone |
| Biohaven Pharmaceuticals, INC. | $18.36 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $15.01 | 2023 | Rexulti |
| Exact Sciences Corporation | $14.50 | 2024 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $13.41 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.65 | 2021 | |
| Sanofi Pasteur INC. | $12.00 | 2021 | |
| Genentech USA, INC. | $10.73 | 2021 | |
| Organon LLC | $8.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Brunson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.